SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Threshold is a project merged from the NuCypher and Keep networks, which strives to provide different threshold cryptography solutions in a fully decentralized manner to the web3 community. Threshold cryptography is a technology that uses cryptography to unlock greater utility and usability for digital assets without needing to trust a centralized party. Threshold cryptography distributes sensitive operations across multiple independent entities – like nodes in a network – and requires a threshold, or minimum number of those entities to cooperate for the operation to be successful.

Threshold Network Token

Threshold Network Token (T) is trending amidst significant community buzz, fueled by recent exchange availability and strong speculation regarding its tBTC solution. Many believe it offers a decentralized alternative for bringing Bitcoin into DeFi, with discussions highlighting its potential to disrupt existing wrapped Bitcoin offerings and lead to substantial growth.

Banco Santander SA is a banking services company, which engages in the provision of banking services to individuals, companies, and institutions. It operates through the following segments: Retail & Commercial Banking, Digital Consumer Bank, Corporate & Investment Banking, Wealth Management & Insurance, Payments, and Corporate Centre. The Retail & Commercial Banking segment integrates the retail banking business (individuals) and commercial banking (SMEs and corporates), except for the consumer finance and the cards businesses. The Digital Consumer Bank segment includes Santander Consumer Finance, which incorporates the entire consumer finance business in Europe, Openbank, and ODS. The Corporate & Investment Banking segment includes Markets, Investment Banking (Global Debt Finance and Corporate Finance) and Global Transactional Banking, offers products and services on a global scale to corporate and institutional customers, and collaborates with other global businesses to better serve broad customer base. The Wealth Management & Insurance segment includes the asset management business (Santander Asset Management), the corporate unit of Private Banking and International Private Banking in Miami and Switzerland and the insurance business (Santander Insurance). The Payments segment involves in the digital payment's solutions, providing global technology solutions for banks and new customers in the open market. The Corporate Centre segment includes the centralized activities relating to equity stakes in financial companies, financial management of the structural exchange rate position. The company was founded on March 21, 1857 and is headquartered in Madrid, Spain.

Banco Santander S.A. - ADR

Banco Santander

Banco Santander is attracting significant attention amid its strategic global repositioning, marked by the divestment of its Polish banking operations and an assertive expansion into the Americas, including a new Canadian banking license and a U.S. partnership with Verizon. The community is actively discussing the bank's strong performance, geographic diversification, and benefits from widening net interest margins across Europe and Latin America, fueling a bullish sentiment despite some technical warnings of being overbought.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending due to a wave of strategic pipeline advancements, including new oncology asset acquisitions and promising Phase 3 results for its investigational HIV regimen, alongside extended patent protection for its blockbuster HIV drug, Biktarvy. The community is actively discussing these moves as a significant diversification and growth strategy, despite some mixed news regarding its Trodelvy cancer drug and competitive landscape concerns. This aggressive expansion in key therapeutic areas and strengthened core franchise are driving investor interest.

The Filecoin network achieves staggering economies of scale by allowing anyone worldwide to participate as storage providers. It also makes storage resemble a commodity or utility by decoupling hard-drive space from additional services. On this robust global market the price of storage will be driven by supply and demand, not corporate pricing departments, and miners will compete on factors like reputation for reliability as well as price.

Filecoin

Filecoin is experiencing renewed interest due to surging demand for decentralized data storage from AI and Web3 projects, with recent network upgrades, record-high storage deals, and a strong presence in the DePIN sector driving conversation. The community views $FIL as a crucial, yet undervalued, piece of infrastructure, actively discussing its potential for significant growth as a foundational layer for verifiable and censorship-resistant data.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

Silver (SLV) is experiencing a historic, parabolic rally, primarily fueled by strong industrial demand for green technology and AI, alongside China's impending export restrictions on the metal. This surge has ignited intense debate within the community, with many anticipating a significant short squeeze and a multi-year 'generational run' driven by physical supply shortages. However, others caution that the rally is an unsustainable 'blow-off top,' noting increased COMEX margin requirements as a potential indicator of an impending correction.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne (S) is trending due to a notable stock decline following its recent earnings report, which featured a slight revenue guidance miss and news of its CFO's departure, despite the company achieving profitability and exceeding current quarter expectations. The community largely views this sell-off as an overreaction, highlighting the stock's perceived undervaluation compared to cybersecurity peers and persistent speculation about a potential acquisition by a larger tech entity. Investors are closely monitoring its AI-native platform's growth and recent bullish options activity, debating if current price levels present a significant long-term opportunity.

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

Medline Inc - Ordinary Shares - Class A

Medline Inc.

Medline (MDLN) is a top trending stock after its substantial public market debut, which has been hailed as the year's largest IPO. The community is enthusiastic about its strong fundamentals and established position as a critical medical supplies provider, positioning it as a durable long-term investment. Many are actively discussing its potential for stable growth within the essential healthcare sector, distinguishing it from more volatile market segments.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is drawing significant attention amid concerns over a spreading severe flu variant and potential bird flu risks, highlighting its mRNA vaccine candidates. Despite a recent market reaction to mixed interim cystic fibrosis data, many perceive the sell-off as overdone, focusing on positive biological signals like mucus plug reduction for an underserved patient group. The community is actively debating the stock's undervaluation, the impact of a trade secret lawsuit against AbbVie, and the potential for a short squeeze as key drivers.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is trending after reporting record Q3 2025 financial results, including significant revenue growth and positive free cash flow, which analysts at KeyBanc acknowledged with an upgrade to Overweight. While recent convertible notes offering and past management actions have drawn community scrutiny, many investors are now discussing a potential turnaround driven by new leadership, its Nasdaq listing, and strategic positioning in edge computing and AI security.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as its spot exchange-traded funds continue to see significant and uninterrupted net cash inflows, signaling robust institutional demand. This consistent interest underscores increasing regulatory clarity and solidifies XRP's role as a crucial bridge asset between traditional finance and the evolving digital economy. The community is actively discussing these unprecedented inflows and the potential for broader adoption within financial systems.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lemonade (NYSE:LMND) Shares Down 6.5% - What's Next?

Lemonade (NYSE:LMND) Shares Down 6.5% - What's Next...

Notable Tuesday Option Activity: LMND, OXY, FUBO

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lemonade Inc (Symbol: LMND), where a total of 15,418 contracts have traded so far...

Lemonade, Inc. $LMND is Halter Ferguson Financial Inc.'s 3rd Largest Position

Halter Ferguson Financial Inc. boosted its stake in shares of Lemonade, Inc. (NYSE:LMND - Free Report) by 101.3% in the third quarter, according to the company in its most recent 13F filing with the...

LMND vs. EVER: Which InsurTech Stock Is the Better Pick?

EVER's strong ROE, AI-driven strategy, and debt-free balance sheet position it ahead of LMND in the InsurTech race.

Lemonade (NYSE:LMND) Sets New 12-Month High - What's Next?

Lemonade (NYSE:LMND) Hits New 1-Year High - Here's What Happened...

Lemonade (LMND) Just Overtook the 20-Day Moving Average

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Lemonade (NYSE:LMND) Stock Price Up 7.9% - Still a Buy?

Lemonade (NYSE:LMND) Stock Price Up 7.9% - Should You Buy...

Tech Innovations to Power Lemonade's Scalable Insurance Model?

LMND's AI-driven model is cutting costs, boosting retention and laying the groundwork for scalable, tech-led growth.

Liontrust Investment Partners LLP Decreases Stake in Lemonade, Inc. $LMND

Liontrust Investment Partners LLP lessened its holdings in shares of Lemonade, Inc. (NYSE:LMND - Free Report) by 34.0% in the second quarter, according to the company in its most recent filing with...

Insider Selling: Lemonade (NYSE:LMND) COO Sells 7,919 Shares of Stock

Lemonade, Inc. (NYSE:LMND - Get Free Report) COO Adina Eckstein sold 7,919 shares of the business's stock in a transaction on Wednesday, December 10th. The stock was sold at an average price of...

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

LMND
Lemonade Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LMND News

LMNDLemonade Inc